New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2022, WHO guidelines for malaria, 25 November 2022.
View latest version (2022)Bibliographic Info
GuidelineWHO guidelines for malaria, 31 March 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
High
Treat children and adults with uncomplicated P. falciparum malaria (except pregnant women in their first trimester) with one of the following ACTs:
- artemether + lumefantrine
- artesunate + amodiaquine
- artesunate + mefloquine
- dihydroartemisinin + piperaquine
- artesunate + sulfadoxine–pyrimethamine (SP).
Notes and Remarks
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Guidelines for the treatment of malaria
Year2015
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 February 2021.
Year2021
InstitutionWHO
Guideline
WHO guidelines for malaria, 13 July 2021.
Year2021
InstitutionWHO
Guideline
WHO guidelines for malaria, 18 February 2022.
Year2022
InstitutionWHO
Guideline
WHO guidelines for malaria, 3 June 2022.
Year2022
InstitutionWHO